Intraperitoneal chemotherapy as first-line treatment of newly diagnosed advanced epithelial ovarian cancer: Two centers' data in China

被引：0
|
作者：
Xie, X. [1 ]
Shen, Y. [1 ]
Tang, S. [1 ]
Cheng, X. [1 ]
Lv, W. [1 ]
Wan, X. [1 ]
Chen, Z. [2 ]
机构：
[1] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.649
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
761
引用
收藏
页码：348 / 348
页数：1
相关论文
共 50 条
  • [1] Modified Intraperitoneal Chemotherapy Without Bevacizumab as a First-Line Therapy for Newly Diagnosed Advanced Epithelial Ovarian Cancer-Two Centers Experiences
    Shen, Yuanming
    Tang, Sangsang
    Xu, Junfen
    Xie, Xing
    Chen, Zhongbo
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Intraperitoneal chemotherapy as first-line treatment in the management of epithelial ovarian cancer
    Rekhraj, S.
    Kinross, J.
    Prabhudesai, S.
    Darzi, A.
    Ziprin, P.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (05) : 509 - 517
  • [3] Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer
    Massard, Christophe
    Lhomme, Catherine
    Pautier, Patricia
    BULLETIN DU CANCER, 2007, 94 (04) : 398 - 404
  • [4] Newly diagnosed ovarian cancer: Which first-line treatment?
    Lorusso, Domenica
    Ceni, Valentina
    Daniele, Gennaro
    Salutari, Vanda
    Pietragalla, Antonella
    Muratore, Margherita
    Nero, Camilla
    Ciccarone, Francesca
    Scambia, Giovanni
    CANCER TREATMENT REVIEWS, 2020, 91
  • [5] Catheter-related complications of intraperitoneal chemotherapy as first-line treatment for advanced epithelial ovarian carcinoma
    Landrum, L. M.
    Gold, M. A.
    Mcmeekin, D. S.
    Walker, J. L.
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 368 - 369
  • [6] Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat, Patrick
    du Bois, Andreas
    Bruchim, Ilan
    Fink, Daniel
    Provencher, Diane M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 62 (02) : 137 - 147
  • [7] First-line Chemotherapy in Epithelial Ovarian Cancer
    Bookman, Michael A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2012, 55 (01): : 96 - 113
  • [8] Six versus nine cycles of paclitaxel-carboplatin as first-line chemotherapy in patients with newly diagnosed epithelial advanced ovarian cancer
    Nayl, B.
    Durando, X.
    Pomel, C.
    Dubray, P.
    Mouret-Reynier, M.
    Le Bouedec, G.
    Gimbergues, P.
    Chollet, P.
    Dauplat, J.
    Cure, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] First-line chemotherapy in advanced ovarian cancer
    Colombo, N
    Parma, G
    Caspani, G
    Donesana, P
    Marinetti, E
    Mangioni, C
    TUMORI JOURNAL, 1999, 85 (03): : S23 - S26
  • [10] First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients
    Romanini, A
    Tanganelli, L
    Carnino, F
    Fanucchi, A
    Lionetto, R
    Pastorino, S
    Cosio, S
    Gadducci, A
    Conte, PF
    GYNECOLOGIC ONCOLOGY, 2003, 89 (03) : 354 - 359
12345